Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-25-000477
Filing Date
2025-01-03
Accepted
2025-01-03 06:09:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea022670503-424b3_cerotherap.htm 424B3 28288
2 GRAPHIC image_001.jpg GRAPHIC 3558
  Complete submission text file 0001213900-25-000477.txt   34512
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283492 | Film No.: 25503673
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)